CSF2 and COVID-19: In our study, multivariable analysis indicated that age was not a determinant in the difference in GM-CSF levels between fatal cases of influenza and COVID-19; this suggests that a disease-specific mechanism that exacerbates age-dependent inflammatory responses is likely to occur in COVID-19.